Sanofi SA (SAN) PT Set at €89.00 by Kepler Capital Markets
SAN has been the topic of a number of other reports. Jefferies Group LLC set a €92.00 ($106.98) target price on shares of Sanofi SA and gave the stock a neutral rating in a research report on Friday, May 12th. Morgan Stanley set a €91.00 ($105.81) target price on shares of Sanofi SA and gave the stock a buy rating in a research report on Tuesday, May 2nd. Sanford C. Bernstein set a €91.00 ($105.81) target price on shares of Sanofi SA and gave the stock a neutral rating in a research report on Tuesday, May 2nd. J P Morgan Chase & Co reaffirmed a neutral rating on shares of Sanofi SA in a research report on Thursday, July 20th. Finally, Deutsche Bank AG set a €96.00 ($111.63) target price on shares of Sanofi SA and gave the stock a buy rating in a research report on Tuesday, April 11th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of €88.00 ($102.33).
Shares of Sanofi SA (SAN) opened at 81.59 on Wednesday. The firm’s 50-day moving average price is €25.48 and its 200 day moving average price is €25.74. The company has a market capitalization of €103.03 billion and a PE ratio of 11.29. Sanofi SA has a 52-week low of €62.50 and a 52-week high of €92.97.
COPYRIGHT VIOLATION WARNING: “Sanofi SA (SAN) PT Set at €89.00 by Kepler Capital Markets” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/sanofi-sa-san-pt-set-at-89-00-by-kepler-capital-markets/1461927.html.
Sanofi SA Company Profile
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Receive News & Ratings for Sanofi SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA and related companies with Analyst Ratings Network's FREE daily email newsletter.